首页> 外国专利> COMPOSITION FOR PREVENTION AND TREATMENT OF LUNG CANCER CONTAINING MUTANT OR EXPRESSION INHIBITOR OF OSTEOPONTIN

COMPOSITION FOR PREVENTION AND TREATMENT OF LUNG CANCER CONTAINING MUTANT OR EXPRESSION INHIBITOR OF OSTEOPONTIN

机译:包含骨桥蛋白突变或表达抑制剂的肺癌的预防和治疗组合物

摘要

PURPOSE: A mutant or inhibitor of osteopontin is provided to prevent and treat lung cancer. CONSTITUTION: An osteopontin mutant has residues in which Thr118, Thr122, Thr127, Thr131 or Thr136 is substituted with alanine. A composition for preventing and treating lung cancer contains the osteopontin mutant. The composition is formulated in an aerosol gene delivery. A composition for preventing and treating lung cancer contains an antisense molecule to osteopontin gene. The antisense molecule is shRNA having nucleotide of sequence numbers 7 and 8.
机译:目的:提供骨桥蛋白的突变体或抑制剂以预防和治疗肺癌。构成:骨桥蛋白突变体具有其中Thr118,Thr122,Thr127,Thr131或Thr136被丙氨酸取代的残基。预防和治疗肺癌的组合物包含骨桥蛋白突变体。将该组合物配制成气雾剂基因递送。预防和治疗肺癌的组合物包含针对骨桥蛋白基因的反义分子。反义分子是具有序列号7和8的核苷酸的shRNA。

著录项

  • 公开/公告号KR20100119085A

    专利类型

  • 公开/公告日2010-11-09

    原文格式PDF

  • 申请/专利权人 SNU R&DB FOUNDATION;

    申请/专利号KR20090038014

  • 发明设计人 CHO MYUNG HAING;CHANG SEUNG HEE;

    申请日2009-04-30

  • 分类号C07K14/51;A61K38/18;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 18:31:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号